September 25, 2020

Volume X, Number 269

September 25, 2020

Subscribe to Latest Legal News and Analysis

September 24, 2020

Subscribe to Latest Legal News and Analysis

September 23, 2020

Subscribe to Latest Legal News and Analysis

September 22, 2020

Subscribe to Latest Legal News and Analysis

Is Stark Law’s “Signed Writing” Requirement Material to Payment: One Federal Court Says Yes

In a case of first impression, a federal court found that the federal physician self-referral law’s (Stark Law) requirement that financial arrangements with physicians be memorialized in a signed writing could be material to the government’s payment decision. This case raises troubling questions about applying the False Claims Act (FCA) to what many in the industry consider “technical” Stark issues, especially given the Supreme Court’s description of the materiality test as “demanding” and not satisfied by “minor or insubstantial” regulatory noncompliance.

United States ex rel. Tullio Emanuele v. Medicor Associates (Emanuele), in the US District Court for the Western District of Pennsylvania, involves Medicor Associates, Inc., a private medical group practice (Medicor), and Hamot Medical Center’s (Hamot) exclusive provider of cardiology coverage. Tullio Emanuele, a qui tam relator and former physician member of Medicor, alleged that Hamot, Medicor, and four of Medicor’s shareholder-employee cardiologists (the Physicians) violated the FCA and Stark Law because Hamot’s multiple medical director compensation arrangements with Medicor failed to satisfy the signed writing requirement in the Stark Law’s personal services or fair market value exceptions during various periods of time. The US Department of Justice declined to intervene in the case, but filed a statement of interest in the summary judgment stage supporting the relator’s position.

In ruling on the summary judgment motions, the court agreed with defendants that six of the eight arrangements met the signed writing requirement, but agreed with relator that a jury could find that two arrangements did not satisfy the signed writing requirement. The court also denied Hamot and Medicor’s motions for summary judgment on the FCA scienter and materiality issues.

The court’s opinion is the first to consider the crucial question of whether and when a false certification of compliance with the signed writing requirements of the applicable Stark Law exception(s) is material to the Medicare program’s payment decision for FCA purposes. First, the court noted that the Stark Law contains an express payment prohibition for claims that originate from referrals by physicians with financial relationships that do not meet an exception, and the relevant exceptions in this case contained a signed writing requirement. Second, the court found that a violation of the signed writing requirement was not “minor or insubstantial” because the requirement creates “transparency and verifiability” and “plays a role in preventing fraud and abuse.” Finally, the court referenced Centers for Medicare and Medicaid Services (CMS) Self-Referral Disclosure Protocol (SRDP) settlements, where disclosures of noncompliance with the Stark Law’s signed writing requirements are common, as an indication that CMS views the writing requirement as material to payment.

While the signed writing requirement helps assure “transparency and verifiability” and plays a role in preventing fraud and abuse, this rationale confuses the materiality of the signed writing to compliance with the Stark Law with the materiality of the signed writing to CMS’ payment decision under the FCA. In the SRDP, CMS consistently allows disclosing parties that have not complied with the signed writing requirement to keep, and not refund, most of the Medicare payments at issue when the violations are discovered and disclosed. This has meant retention of tens, perhaps hundreds, of millions of dollars in Medicare payments by hospitals that did not comply with the signed writing requirement, and, in and of itself, demonstrates that even CMS appears to consider such violations to be garden-variety and relatively minor. Further, the outcome in Emanuele seems inconsistent with the Supreme Court’s direction to interpret the materiality standard as “demanding” and caution that the FCA is not an all-purpose antifraud statute or a vehicle for punishing garden-variety breaches of contract or regulatory violations.

The argument for treating a failure to satisfy the signed writing requirement as “minor or insubstantial” is not an argument that the requirement is not meaningful and important to the prevention of fraud and abuse or to compliance with the Stark Law. It goes without saying that, if Congress included a signed writing requirement in the law, the requirement is important, and noncompliance with the requirement is noncompliance with the Stark Law. However, the fact that the signed writing requirement is meaningful and important to both the prevention of fraud and abuse, and to compliance with the Stark Law, does not end the examination of whether such noncompliance is necessarily material to Medicare’s payment decision for purposes of the FCA.

Many hospitals and health systems today have contract management and accounts payable protocols in place that reduce the risk of noncompliance with the Stark Law’s signed writing requirements and, importantly, help establish that any particular failure was not deliberate or due to reckless disregard for compliance with the requirement. Emanuele is a discouraging reminder that even an innocent failure to discover and disclose signed writing or other technical Stark violations could result in the harsh choice between a high-risk trial or an expensive settlement under the FCA.

© 2020 McDermott Will & EmeryNational Law Review, Volume VII, Number 131


About this Author

Joshua Buchanan, McDermott Law Firm, While Collar Criminal Defense Attorney

Joshua (Josh) T. Buchman focuses his practice on white-collar criminal defense, internal investigations and complex commercial litigation. He represents corporate clients in the health care, manufacturing and defense contracting industries, in civil litigation and in corporate internal investigations. Josh has deep knowledge of False Claims Act litigation, and obtained a complete victory for a defense contractor client in a case involving $600 million in single damages exposure. He also represents individuals involved in government investigations.

Tony Maida Health Care Attorney McDermott WIll Law Firm

Tony Maida is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s New York office.  Tony has extensive experience in health care fraud and abuse and compliance issues, including the federal Anti-Kickback and Physician Self-Referral/Stark laws, false claims and overpayments, and government investigations.    He works closely with our health and white collar teams on criminal, civil, and administrative investigations and counseling clients on corporate transactions and compliance programs.

Tony previously served as a senior official in the Office of Counsel to the Inspector General at the United States Department of Health and Human Services, where he worked for nine years.  As Deputy Chief of the Administrative and Civil Remedies Branch, Tony led a team of attorneys representing the agency on False Claims Act and Civil Monetary Penalty Law cases, including conducting investigations and negotiating settlements and Corporate Integrity Agreements in some of the largest settlements obtained by the United States.  He participated in defending the OIG in numerous exclusion appeals, including appeals pursued by high-level corporate executives.  

1 212 547 5492

Daniel H. Melvin is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm's Chicago office.  Daniel focuses his practice on counseling clients on Federal health care program fraud and abuse, Stark law, and Medicare reimbursement issues. 

Joan Polacheck, Health Care industry Lawyer, McDermott Will Emery, Chicago Law Firm

Joan Polacheck is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Chicago office. She represents a broad range of health care industry clients, including hospitals, suppliers, and drug and device companies.

Rebecca Waltuch, McDermott Law Firm, Healthcare Attorney

Rebecca Waltuch provides legal counsel on general health law, including the representation of hospitals, health systems and other health care clients. She focuses her practice on counseling clients on a range of regulatory issues, including federal health care program fraud and abuse and the Stark law, as well as the Health Insurance Portability and Accountability Act (HIPAA) and other state and federal data privacy and security laws. Rebecca serves as the lead lawyer for physician contracting matters for a large hospital system. She advises accountable care organization (ACO) clients on...